OR WAIT null SECS
November 23, 2021
Transaction is anticipated to further Novo’s research in the field of RNAi therapeutics
November 22, 2021
Acquisition of biopharma company features sotatercept, which is in Phase III trials for the treatment of pulmonary arterial hypertension
Financial commitment expected to increase plant's process development and manufacturing capacity
November 17, 2021
Industrialized collaboration is critical to taking next-generation cell and gene therapies to the next level—if companies can build on pandemic-partnering momentum
November 12, 2021
Separation process expected to be completed in 18-24 months
November 11, 2021
Expansion expected to more than double the plant’s footprint
November 10, 2021
CDMO’s expansion of Hopkinton, MA facility will include seven new ISO 7 cGMP suites
November 09, 2021
Deal expected to boost firm’s offerings via FDS's delivery system services
Partnership further increases investment firm’s repertoire in healthcare space
November 08, 2021
Boston area facility will focus heavily on cold chain services